Literature DB >> 16152657

Characterization of the human blood plasma proteome.

Yufeng Shen1, Jeongkwon Kim, Eric F Strittmatter, Jon M Jacobs, David G Camp, Ruihua Fang, Nikola Tolié, Ronald J Moore, Richard D Smith.   

Abstract

We describe methods for broad characterization of the human plasma proteome. The combination of stepwise immunoglobulin G (IgG) and albumin protein depletion by affinity chromatography and ultrahigh-efficiency capillary liquid chromatography separations coupled to ion trap-tandem mass spectrometry enabled identification of 2392 proteins from a single plasma sample with an estimated confidence level of > 94%, and an additional 2198 proteins with an estimated confidence level of 80%. The relative abundances of the identified proteins span a range of over eight orders of magnitude in concentration (< 30 pg/mL to approximately 30 mg/mL), facilitated by the attomole-level sensitivity of the analysis methods. More than 80% of the observed proteins demonstrate interactions with IgG and/or albumin, and the human plasma protein loss in the affinity chromatography/strong cation exchange/reversed-phase liquid chromatography-tandem mass spectrometry methodology was investigated in detail. The results of this study provide a basis for a wide range of plasma proteomics studies, including broad quantitation of relative abundances in comparative studies of the identification of novel protein disease markers, as well as further studies of protein-protein interactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16152657     DOI: 10.1002/pmic.200401246

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  36 in total

1.  One-step sample concentration, purification, and albumin depletion method for urinary proteomics.

Authors:  Ali R Vaezzadeh; Andrew C Briscoe; Hanno Steen; Richard S Lee
Journal:  J Proteome Res       Date:  2010-10-15       Impact factor: 4.466

Review 2.  The blood peptidome: a higher dimension of information content for cancer biomarker discovery.

Authors:  Emanuel F Petricoin; Claudio Belluco; Robyn P Araujo; Lance A Liotta
Journal:  Nat Rev Cancer       Date:  2006-11-09       Impact factor: 60.716

3.  Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometry.

Authors:  Arti Navare; Manshui Zhou; John McDonald; Fernando G Noriega; M Cameron Sullards; Facundo M Fernandez
Journal:  Rapid Commun Mass Spectrom       Date:  2008-04       Impact factor: 2.419

4.  Plasma proteomic analysis of patients with squamous cell carcinoma of the uterine cervix.

Authors:  Dae Hoon Jeong; Hyoung Kyu Kim; Abd-Ei Bary Prince; Dae Sim Lee; Young Nam Kim; Jin Han; Ki Tae Kim
Journal:  J Gynecol Oncol       Date:  2008-09-30       Impact factor: 4.401

Review 5.  Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Authors:  Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
Journal:  J Biomed Biotechnol       Date:  2009-12-06

6.  High dynamic range characterization of the trauma patient plasma proteome.

Authors:  Tao Liu; Wei-Jun Qian; Marina A Gritsenko; Wenzhong Xiao; Lyle L Moldawer; Amit Kaushal; Matthew E Monroe; Susan M Varnum; Ronald J Moore; Samuel O Purvine; Ronald V Maier; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-05-09       Impact factor: 5.911

7.  Affinity enrichment for mass spectrometry: improving the yield of low abundance biomarkers.

Authors:  Brianna Kim; Robyn Araujo; Marissa Howard; Ruben Magni; Lance A Liotta; Alessandra Luchini
Journal:  Expert Rev Proteomics       Date:  2018-03-22       Impact factor: 3.940

Review 8.  Proteomic contributions to personalized cancer care.

Authors:  John M Koomen; Eric B Haura; Gerold Bepler; Rebecca Sutphen; Elizabeth R Remily-Wood; Kaaron Benson; Mohamad Hussein; Lori A Hazlehurst; Timothy J Yeatman; Lynne T Hildreth; Thomas A Sellers; Paul B Jacobsen; David A Fenstermacher; William S Dalton
Journal:  Mol Cell Proteomics       Date:  2008-07-29       Impact factor: 5.911

9.  Dual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodies.

Authors:  Christoph Schröder; Anette Jacob; Sarah Tonack; Tomasz P Radon; Martin Sill; Manuela Zucknick; Sven Rüffer; Eithne Costello; John P Neoptolemos; Tatjana Crnogorac-Jurcevic; Andrea Bauer; Kurt Fellenberg; Jörg D Hoheisel
Journal:  Mol Cell Proteomics       Date:  2010-02-16       Impact factor: 5.911

10.  Proteomic signatures in plasma during early acute renal allograft rejection.

Authors:  Gabriela V Cohen Freue; Mayu Sasaki; Anna Meredith; Oliver P Günther; Axel Bergman; Mandeep Takhar; Alice Mui; Robert F Balshaw; Raymond T Ng; Nina Opushneva; Zsuzsanna Hollander; Guiyun Li; Christoph H Borchers; Janet Wilson-McManus; Bruce M McManus; Paul A Keown; W Robert McMaster
Journal:  Mol Cell Proteomics       Date:  2010-05-25       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.